Literature DB >> 15619643

Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.

Mehar Chand Sharma1, Angela Mercy Ralte, Shailesh Gaekwad, Vani Santosh, S K Shankar, Chitra Sarkar.   

Abstract

Subependymal giant cell astrocytomas (SEGAs) are relatively rare tumors but occur commonly in the setting of the familial syndrome of tuberous sclerosis complex (TSC). In view of its varied morphology, i.e. resemblance to astrocytic and ganglion cells, its histogenesis remains controversial. We studied 23 cases of SEGA, 19 from our own institute and 4 from NIMHANS, Bangalore. These 19 cases of SEGAs were collected over a period of 23 years (1979 to 2001), and accounted for 0.16% of intracranial tumors and 0.51% of all gliomas reported at our center. The majority of patients presented with visual disturbances (19/23, 82.6%) in the form of decreased vision (60.8%) and blindness (21.7%), generalized tonic clonic seizures (43.4%) and focal motor seizures (4.37%). Age ranged from 4 to 37 years (mean 13.2 years) with male predominance (M:F 2.2:1), and the duration of symptoms varied from 1 month to 96 months (mean 17.2 months). Lateral ventricular involvement was the most common site (91.3%), followed by the third ventricle (8.6%). Nine patients (39.1%) had stigmata of tuberous sclerosis (6 at the time of diagnosis and 3 in the follow-up period). Two patients died due to surgical complications, while the rest were alive and well in the follow-up period ranging from 3 to 264 months (mean 37.1 months). Two patients experienced recurrences, one two years and another 22 years after surgery. Microscopic examination showed varied histology consisting of sweeping bundles of spindle cells, gemistocyte and ganglion-like cells with interspersed inflammatory cell component. The inflammatory cell component on special staining turned out to be an admixture of mast cells and T lymphocytes. Six cases showed areas of necrosis and/or mitosis, but were not indicative of aggressive nature of this tumor. Immunoreactivity for GFAP, NF, S-100, NSE and synaptophysin indicates that this is a hybrid tumor with glial and neuronal differentiation. None of the tumors was immunopositive for HMB-45. The significance of the presence of T lymphocytes and mast cells is not clear. It could be related to tumor immunology and may indicate a favorable prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15619643     DOI: 10.1007/BF03033764

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney.

Authors:  M Pea; F Bonetti; G Zamboni; G Martignoni; M Riva; R Colombari; A Mombello; M Bonzanini; A Scarpa; C Ghimenton
Journal:  Pathology       Date:  1991-07       Impact factor: 5.306

2.  Immunohistochemical characterization of subependymal giant cell astrocytomas.

Authors:  M B Lopes; H J Altermatt; B W Scheithauer; C W Shepherd; S R VandenBerg
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

3.  Brain hamartomas and tumors associated with tuberous sclerosis.

Authors:  C P Boesel; G W Paulson; E J Kosnik; K M Earle
Journal:  Neurosurgery       Date:  1979-05       Impact factor: 4.654

4.  Ultrastructure of tuberous sclerosis: cortical tuber and subependymal tumor.

Authors:  I K Trombley; S S Mirra
Journal:  Ann Neurol       Date:  1981-02       Impact factor: 10.422

5.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.

Authors:  T Al-Saleem; L L Wessner; B W Scheithauer; K Patterson; E S Roach; S J Dreyer; K Fujikawa; J Bjornsson; J Bernstein; E P Henske
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

7.  [Histogenesis of subependymal glioma in Bourneville's tuberous sclerosis].

Authors:  B Bancel; M F Belin; A Meiniel; M Didier; M Aguera; M Tommasi; J Pialat
Journal:  Ann Pathol       Date:  1990       Impact factor: 0.407

8.  Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis.

Authors:  F Bonetti; P L Chiodera; M Pea; G Martignoni; F Bosi; G Zamboni; G M Mariuzzi
Journal:  Am J Surg Pathol       Date:  1993-11       Impact factor: 6.394

9.  Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis.

Authors:  K Stefansson; R Wollmann
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

10.  Central nervous system pathology of tuberous sclerosis in children.

Authors:  B L Bender; E J Yunis
Journal:  Ultrastruct Pathol       Date:  1980 Jul-Sep       Impact factor: 1.094

View more
  16 in total

1.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 2.  Giant cell ependymoma-report of three cases and review of the literature.

Authors:  Jian Yi Li; Jose I Lopez; Suzanne Z Powell; Stephen W Coons; Gregory N Fuller
Journal:  Int J Clin Exp Pathol       Date:  2012-05-05

3.  Hippocampal dysplasia with balloon cells: case report and discussion on classification.

Authors:  Fabio Rogerio; Marcia Elisabete Morita; Ana Carolina Coan; Carlos Alberto Mantovani Guerreiro; Helder Tedeschi; Roland Coras; Luciano de Souza Queiroz; Ingmar Blümcke; Fernando Cendes
Journal:  J Neurol       Date:  2014-09-07       Impact factor: 4.849

Review 4.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

Review 5.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  Giant cells: contradiction to two-hit model of tuber formation?

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

Review 7.  Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.

Authors:  Moncef Berhouma
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

Review 8.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

9.  Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.

Authors:  Martine Fohlen; Sarah Ferrand-Sorbets; Olivier Delalande; Georg Dorfmüller
Journal:  Childs Nerv Syst       Date:  2018-05-15       Impact factor: 1.475

Review 10.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.